Rutger Koning Selected Research

Rutger Koning Research Topics

6	COVID-19 01/2023 - 12/2020
2	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2024 - 12/2022
2	Inflammation (Inflammations) 01/2023 - 12/2020
2	Pneumonia (Pneumonitis) 01/2021 - 12/2020
1	Necrosis 01/2023
1	Central Nervous System Infections (Central Nervous System Infection) 12/2022
1	Asymptomatic Infections 01/2021
1	Dyspnea (Shortness of Breath) 12/2020
1	Multiple Sclerosis 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Neuroinflammatory Diseases 01/2020

4	AutoantibodiesIBA 01/2022 - 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2023
1	ChemokinesIBA 01/2023
1	ThrombomodulinIBA 01/2023
1	CytokinesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Streptococcus pneumoniae plY proteinIBA 12/2022
1	Interferon Type IIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 12/2020
1	Complement System Proteins (Complement)IBA 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	AnaphylatoxinsIBA 12/2020
1	vilobelimabIBA 12/2020
1	Methionine (L-Methionine)FDA Link 01/2020

1	Therapeutics 01/2024